These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 11270999)
21. Comparative pharmacokinetics of isosorbide nitrates after repeated doses of sustained release isosorbide dinitrate. Laufen H; Leitold M; Wildfeuer A Arzneimittelforschung; 1988 Sep; 38(9):1336-41. PubMed ID: 3223973 [TBL] [Abstract][Full Text] [Related]
22. [Biological availability and pharmacodynamics following single oral administration or three different sustained-release isosorbide-5-mononitrate dosage forms]. Merz PG; Thürmann P; Harder S Arzneimittelforschung; 1992 Jan; 42(1):21-4. PubMed ID: 1586375 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of isosorbide mononitrate in a new sustained release oral form in comparison with a conventional formulation. Gandini R; Cunietti E; Assereto R; Castoldi D; Tofanetti O; Baggio E Arzneimittelforschung; 1987 Jul; 37(7):836-9. PubMed ID: 3675680 [TBL] [Abstract][Full Text] [Related]
24. Bioavailability and pharmacokinetics of a new isosorbide dinitrate spray preparation in healthy volunteers. Hutt V; Theodor R; Pabst G; Lutz D; Bonn R; Fritschi E Arzneimittelforschung; 1993 Aug; 43(8):842-6. PubMed ID: 8216439 [TBL] [Abstract][Full Text] [Related]
25. In vitro dissolution and in vivo bioequivalence evaluation of two brands of isosorbide 5-mononitrate sustained release tablets. Kim YH; Choi KS; Kam SH; Lee KH; Park JS Arzneimittelforschung; 2012 Dec; 62(12):576-82. PubMed ID: 23093481 [TBL] [Abstract][Full Text] [Related]
26. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate]. Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of bioavailability and pharmacokinetics of two isosorbide-5-mononitrate preparations in healthy volunteers. Hutt V; Theodor R; Pabst G; Bonn R; Fritschi E; Jaeger H J Clin Pharmacol; 1992 Jun; 32(6):553-7. PubMed ID: 1634643 [TBL] [Abstract][Full Text] [Related]
28. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs]. Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793 [TBL] [Abstract][Full Text] [Related]
29. [Gas chromatographic method with EC detection to determine isosorbide-5-mononitrate (IS-5-MN) in human serum and its pharmacokinetic parameters]. Xia GZ; Fu YK; Dong SN; Li R Yao Xue Xue Bao; 1994; 29(8):634-8. PubMed ID: 7985521 [TBL] [Abstract][Full Text] [Related]
30. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations. Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789 [TBL] [Abstract][Full Text] [Related]
31. [Bioavailability of isosorbide-5-mononitrate from delayed-action formulations]. Taylor T; Major RM; Leaf FC; Cook SC; Chasseaud LF; Darragh A; Lambe RF Arzneimittelforschung; 1984; 34(11):1584-7. PubMed ID: 6543135 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of bendazac lysine in 10 Chinese young men. Chen XX; Zhang YD; Shen JP; Pu J; Yan HY; Zhu YQ; Qiu JJ Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):109-11. PubMed ID: 10072958 [TBL] [Abstract][Full Text] [Related]
33. Development of monolithic osmotic pump tablet system for isosorbide-5-mononitrate delivery and evaluation of it in vitro and in vivo. Duan X; Liu Q; Zhang Y; Bi K; Chen X; Wang Y; Luo G Drug Dev Ind Pharm; 2009 Apr; 35(4):499-507. PubMed ID: 18979308 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of anastrozole in Chinese male volunteers. Yuan J; Wang PQ; Ge SR; An FR; Shi AG; Chen J; Liang JY Acta Pharmacol Sin; 2001 Jun; 22(6):573-6. PubMed ID: 11747767 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic profile of a new controlled-release isosorbide-5-mononitrate 60 mg scored tablet (Monoket Multitab). Stockis A; De Bruyn S; Deroubaix X; Jeanbaptiste B; Lebacq E; Nollevaux F; Poli G; Acerbi D Eur J Pharm Biopharm; 2002 Jan; 53(1):49-56. PubMed ID: 11777752 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetics of erythromycin stinoprate capsule]. Wang LQ; Hu ZY; Yu Q; Guo X; Xiong J; Huang ZZ; Cheng ZN Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):197-201. PubMed ID: 15898434 [TBL] [Abstract][Full Text] [Related]
37. Absorption of isosorbide-5-mononitrate at specific sites in the gastrointestinal tract. Kramer WG J Clin Pharmacol; 1994 Dec; 34(12):1218-21. PubMed ID: 7738218 [TBL] [Abstract][Full Text] [Related]
38. [Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions]. Rietbrock N; Knoll J; Merz PG; Menke G Dtsch Med Wochenschr; 1985 Nov; 110(47):1821-5. PubMed ID: 3905327 [TBL] [Abstract][Full Text] [Related]
39. A pharmacokinetic model for isosorbidedinitrate, isosorbide-2-mononitrate, and isosorbide-5-mononitrate. Smith D; Aldrich W; Dey M; Enever R; Warner R; Weierstall R Drug Metab Dispos; 1990; 18(4):429-34. PubMed ID: 1976063 [TBL] [Abstract][Full Text] [Related]
40. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]